tapinarof

Ligand id: 9686

Name: tapinarof

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 0
Hydrogen bond donors 2
Rotatable bonds 3
Topological polar surface area 40.46
Molecular weight 254.13
XLogP 5.04
No. Lipinski's rules broken 1

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
Topically applied tapinarof (research code GSK2894512) has shown clinical efficacy in Phase 2 clinical trial in patients with plaque psoriasis [1] (NCT02564042). A Phase 3 trial (NCT03202004) is ready to recruit subjects (Oct 2017). Tapinarof has also completed Phase 1 studies for atopic dermatitis.
Mechanism Of Action and Pharmacodynamic Effects
The AhR is a cytosolic ligand-activated transcription factor that senses a wide range of endogenous and exogenous molecules and influences multiple biological activities. IIn the immune system it acts as a regulator of innate and adaptive immune responses, impacting the balance of Th17 and Treg cells. Tapinarof modulates the immune response via an agonistic interaction with the AhR [2].